I’ve been reflecting on the parallels between two seemingly disparate worlds: in vitro fertilization (IVF) and startup investing. As an IVF specialist and active angel investor, I find myself immersed in both domains daily, and I’ve come to realize that the journeys within each are as unique as the individuals and ideas that embark upon them.
Just last week, I met a couple embarking on their first IVF cycle. Their eyes were filled with a mix of hope and trepidation, a familiar look I often see in the eyes of first-time founders. While the stakes in IVF and startups are different, the emotional rollercoaster is strikingly similar. Each IVF journey is distinct, filled with its own challenges, triumphs, and disappointments. Similarly, no two startup journeys are identical; each path is carved out by unique visions, market conditions, and personal tenacity.
In my experience, IVF is more than a medical procedure. It’s a deeply personal voyage that requires patience, resilience, and unwavering commitment. The same can be said for startups. The founders who succeed are those who understand that the road is long and fraught with unexpected turns. They are not deterred by initial failures; instead, they learn and adapt, much like the couples I counsel during fertility treatments.
The IVF process begins with thorough preparation, akin to the groundwork a founder must lay before launching a new venture. Both require a deep understanding of one’s capabilities and limitations. For every IVF cycle, we conduct extensive fertility testing and medical history reviews, tailoring the approach to the individual’s needs. Similarly, a startup must conduct market research and competitive analysis before crafting a business model tailored to its unique value proposition.
When it comes to ovarian stimulation in IVF, we aim to maximize the chances of success by encouraging the production of multiple eggs. This process involves monitoring and adjusting hormone levels meticulously—a practice not unlike adjusting a startup’s strategy in response to market feedback. A founder must be agile, ready to pivot when necessary to seize opportunities or mitigate risks.
The egg retrieval phase in IVF is a critical juncture, much like a startup’s funding round. Both are pivotal moments that require precision and timing. In IVF, it involves collecting mature eggs at the optimal time to enhance the chances of fertilization. For a startup, securing funding is about timing and positioning; a misstep can mean the difference between success and a missed opportunity.
Fertilization in the lab is where the magic happens in IVF, and it’s akin to the moment a startup’s product begins to resonate with its target audience. In both cases, the initial signs of success are thrilling, but they are merely the beginning. The real challenge lies in nurturing that potential—whether it’s developing embryos to the blastocyst stage or scaling a product to meet growing demand.
Embryo development and transfer are delicate stages, requiring careful observation and decision-making. Not every embryo will thrive, just as not every product feature will resonate with customers. The key is to focus on what works and be ready to adjust. For startups, this means iterating based on user feedback and market trends. For IVF, it means making informed decisions about which embryos to transfer or freeze for future attempts.
The two-week wait after an embryo transfer is perhaps the most emotionally taxing part of the IVF journey. It’s a period filled with hope and uncertainty, mirroring the anxiety founders feel while waiting for user feedback or investment decisions. In both cases, success is never guaranteed, but the possibility of achieving one’s dreams makes the journey worthwhile.
For me, the most important lesson from both IVF and startups is the importance of resilience. In IVF, success often comes after multiple attempts, teaching us the value of persistence and adaptation. Similarly, many successful startups are born out of failure and the willingness to learn from mistakes. As I reflect on these journeys, I see that each step, each setback, and each victory is a testament to the human spirit’s ability to innovate and persevere.
In my experience, both fields require a delicate balance of science and art—clinical precision and emotional intelligence. Whether you’re navigating the complexities of fertility treatments or the dynamic landscape of a startup, it’s crucial to trust the process and remain open to learning. After all, it’s not just about the destination; it’s about the growth and transformation that happen along the way.
As I continue to work with patients and founders, I’m reminded that the true measure of success is not just in the outcomes but in the courage to embark on these unique journeys. Whether you’re pursuing parenthood through IVF or launching a startup, remember that your path is uniquely yours. Embrace it with patience, resilience, and an open heart, and the rewards—be they personal fulfillment, deeper relationships, or the realization of your dreams—will be well worth the effort.